Home
Contact
1. What is the composition of UrgoCell® START Contact?
2. Does UrgoCell® START Contact affect the pH of the wound?
3. Can UrgoCell® START Contact be used with antiseptics?
4. Can UrgoCell® START Contact be used on infected wounds?
5. Is there any risk of the wound drying out?
6. What are the contraindications of UrgoCell® START Contact?
7. Is there evidence that UrgoCell® START Contact is effective?
9. What role do MMPs play in normal healing?
10. What is Nano-OligoSaccharide Factor (NOSF) and what is its role?
11. Why is the UrgoCell® START Contact range different from other treatments?
12. What is the composition of UrgoCell® START Contact?
13. Does UrgoCell® START Contact improve fragile surrounding skin?
14. Can UrgoCell® START Contact be used on cavity wounds?
15. Is UrgoCell® START Contact easy to handle? Does UrgoCell® START Contact stick to gloves?
16. How often should UrgoCell® START Contact dressings be changed?
1. What is the definition of UrgoCell® START Contact?
UrgoCell® START Contact is a soft-adherent foam dressing with TLC-NOSF technology, an innovation from URGO. It consists of two layers: a highly breathable backing, and an absorbent foam pad coated with a soft-adherent TLC-NOSF layer. The NOSF restores the biochemical balance of the wound by regulating the action of MMPs and the Soft-Adherent TCL-layer stimulates fibroblast proliferation. The foam and the backing control exudate without maceration.
2. Does UrgoCell® START Contact affect the pH of the wound?
UrgoCell® START Contact has a neutral pH, so it has no influence on the wound.
3. Can UrgoCell® START Contact be used with antiseptics?
After having performed the usual wound care protocol and prior to application of UrgoCell® START Contact, it is recommended that the wound be rinsed with sterile saline solution.
5. Can UrgoCell® START Contact be used on infected wounds?
In the case of a wound showing signs of bacterial colonisation, it is recommended that the bacterial infection be treated first by UrgoCell® Silver, prior to the use of UrgoCell® START Contact.
6. Is there any risk of the wound drying out?
No. When in contact with the exudate, the dressing forms a lipido-colloid gel, which creates and maintains the moist environment favourable to the healing process.
7. What are the contraindications of UrgoCell® START Contact?
UrgoCell® START Contact is contraindicated in the case of cancerous wounds and deep fistula wounds.
8. Is there evidence that UrgoCell® START Contact is effective?
In a Randomised Controlled Trial conducted on 117 patients, it was demonstrated that the healing rate was multiplied by 4 versus the comparative MMP inhibitor product, due to the action of TLC-NOSF (Schmutz JL, Meaume S, Fays S et al. Evaluation of the nano-oligosaccharid factor lipido-colloid matrix in the local management of venous leg ulcers : results of a randomised, controlled trial, Int Wound J. 2008 jun,6(2); 172-82)
The UrgoCell ® START TLC dressing significantly stimulates human fibroblast proliferation, which has been observed and demonstrated with UrgoCell ® TLC and TLC dressings (Bernard F.X. et al. Stimulation of the proliferation of human dermal fibroblasts in vitro by a lipidocolloid dressing. Journal of Wound Care. 2005. Clinical study in course).
UrgoCell® START Contact is available in a variety of different sizes for cost-effectiveness. It can be cut to shape the dressing to the size of the wound.
10. What role do MMPs play in normal healing?
During the inflammation phase that occurs in the wound healing process, MMPs (Matrix Metallo-Proteinases) help to eliminate fragments of damaged tissue in the extracellular matrix, thereby promoting the reconstruction of a new matrix. In order to protect healthy tissue from excessive MMP activity, MMP inhibitors are synthesised physiologically. In the case of a chronic wound, this balance is disrupted and MMPs have increased activity. The NOSF present in UrgoCell® START Contact inhibitit the action of MMPs and restores the physiological balance.
11. What is Nano-OligoSaccharide Factor (NOSF) and what is its role?
NOSF, Nano-OligoSaccharide Factor is a proteinase inhibitor, which inhibits certain MMPs in order to restore the biochemical balance in wounds. Restoration of the balance between MMPs and MMP inhibitors re-triggers the healing process.
12. Why is the UrgoCell® START Contact range different from other treatments?
The UrgoCell® START Contact range contains a unique and innovative active substance, NOSF, a proteinase inhibitor capable of re-triggering the healing process in leg ulcers, pressure ulcers and diabetic foot ulcers.
13. What is the composition of UrgoCell® START Contact?
UrgoCell® START Contact consists of two layers: a highly breathable backing and a super-absorbent foam coated with a micro-adherent TLC-Contact NOSF matrix. The TLC-Contact NOSF matrix accelerates the healing process. The foam and the backing control exudates without maceration.
14. Does UrgoCell® START Contact improve fragile surrounding skin?
Due to its non-occlusive and non-adhesive lipido-colloid matrix, UrgoCell® START Contact improves the condition of the peri-wound skin.
15. Can UrgoCell® START Contact be used on cavity wounds?
No, the limited conformability of UrgoCell® START Contact means that it is not ideal for use in cavity wounds. It is recommended that Urgotul® START be used in these cases (contact layer with TLC-NOSF).
16. Is UrgoCell® START Contact easy to handle? Does UrgoCell® START Contact stick to gloves?
UrgoCell® START Contact has tabs for easy application. The soft-adherent TLC layer of UrgoCell® START Contact may sticks to latex surgical gloves. It is therefore recommended to avoid contact with this soft-adherent TLC layer.
17. How often should UrgoCell® START Contact dressings be changed?
UrgoCell® START Contact dressings can be left in place for up to 7 days, depending on the level of exudate and the clinical condition of the wound.